Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
NCT02593734 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 139
Last updated 2015-11-02
Summary
The purpose of this study is to evaluate a bundled intervention of psychotropic drugs and daily contact with a nurse for people with mental health disorders in a prayer camp and secondly to assess whether the attitudes of the prayer camp staff toward mental health disorders and conventional medicines remain the same after the intervention.
Conditions
- Schizophrenia
- Mood Disorders,
- Anxiety Disorder
Interventions
- DRUG
-
oral antipsychotic drug therapy
- DRUG
-
risperidone
oral antipsychotic drug therapy
- DRUG
-
amitryptaline
oral antidepressant drug therapy
- DRUG
-
fluoxetine
oral drug therapy for depression
Sponsors & Collaborators
-
University of Ghana Medical School
lead OTHER
Principal Investigators
-
Angela L Ofori-Atta, PhD · University of Ghana Medical School
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2015-07-31
- Completion
- 2015-07-31
Countries
- Ghana
Study Locations
More Related Trials
-
Identification and Treatment of the Liability to Develop Schizophrenia
NCT00305474 ·Status: UNKNOWN ·Phase: PHASE4
-
Antipsychotic to Treat Psychosis Syndrome
NCT02137616 ·Status: UNKNOWN ·Phase: NA
-
A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting
NCT01926912 ·Status: COMPLETED
-
A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices
NCT00237939 ·Status: COMPLETED ·Phase: PHASE3
-
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
NCT01181960 ·Status: COMPLETED
-
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
NCT03557931 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
NCT00616798 ·Status: COMPLETED ·Phase: PHASE2
-
An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia
NCT00257023 ·Status: COMPLETED ·Phase: PHASE2
-
Standard Comprehensive Intervention to Treat First-episode Schizophrenia
NCT01057849 ·Status: UNKNOWN ·Phase: NA
-
An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia
NCT02640911 ·Status: RECRUITING
-
A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities
NCT03713658 ·Status: COMPLETED ·Phase: PHASE4
-
Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia
NCT00159133 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Seroquel in First Episode Schizophrenia
NCT00254241 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
NCT02431702 ·Status: COMPLETED ·Phase: PHASE3
-
Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication
NCT00287027 ·Status: TERMINATED
-
The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation
NCT02935998 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
NCT00292409 ·Status: COMPLETED ·Phase: PHASE3
-
Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics
NCT03730857 ·Status: COMPLETED ·Phase: PHASE1
-
Switching Medication to Treat Schizophrenia
NCT00044655 ·Status: COMPLETED ·Phase: PHASE4
-
Optimization of Acute Treatment in First Episode Schizophrenia
NCT00157378 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation
NCT00250354 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone
NCT00535132 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Risperidone Monotherapy in Bipolar Anxiety
NCT00167479 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Antidepressants or Antipsychotics in Preventing Psychosis
NCT01724372 ·Status: WITHDRAWN ·Phase: NA
-
Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia
NCT00139737 ·Status: COMPLETED ·Phase: PHASE3